Abstract
The inhibitory action of cardiac glycosides on active Na + and K + transport across the cell membrane had been demonstrated in the early 1950 s (Schatzmann, 1953; see Hajdu and Leonard, 1959). Thus, with the discovery of Na +, K+-ATPase (Skou, 1957; Hess and Pope, 1957), the effect of these glycosides on the enzyme activity was examined and a specific inhibition was observed (Post et al., 1960; Skou, 1960; see Fig. 1). The interaction of cardiac glycosides with the enzyme, and its possible relationship to the pharmacologic or toxic actions of these agents have been extensively studied during the last two decades (see the following review articles: Glynn, 1964; Repke, 1964, 1965; Skou, 1965; Langer, 1971, 1972a; Lee and Klaus, 1971; Smith and Haber, 1973; Schwartz et al., 1975; Akera and Brody, 1976, 1977; Akera, 1977; Brody and Akera, 1977; Langer, 1977; Okita, 1977; Wallick et al., 1977).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmed, K., Judah, J.D.: On the action of strophanthin G. Can. J. Biochem. 43, 877–880 (1965)
Akera, T.: Quantitative aspects of the interaction between ouabain and (Na ++K+)-activated ATPase in vitro. Biochim. Biophys. Acta (Amst.) 249, 53–62 (1971)
Akera, T.: Membrane adenosinetriphosphatase: A digitalis receptor? Science 198, 569–574 (1977)
Akera, T., Brody, T.M.: Membrane adenosine triphosphatase: The effect of potassium on the formation and dissociation of the ouabain-enzyme complex. J. Pharmacol. Exp. Ther. 176, 545–557 (1971)
Akera, T., Brody, T.M.: Inotropic action of digitalis and ion transport. Life Sci. 18, 135–142 (1976)
Akera, T., Brody, T.M.: The role of Na+, K+-ATPase in the inotropic action of digitalis. Pharmacol. Rev. 29, 187–220 (1977)
Akera, T., Cheng, V.-J.K.: A simple method for the determination of affinity and binding site concentration in receptor binding studies. Biochim. Biophys. Acta (Amst.) 470, 412423 (1977)
Akera, T., Larsen, F.S., Brody, T.M.: The effect of ouabain on sodium-and potassium-activated adenosine triphosphatase from the hearts of several mammalian species. J. Pharmacol. Exp. Ther. 170, 17–26 (1969)
Akera, T., Larsen, F.S., Brody, T.M.: Correlation of cardiac sodium-and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation. J. Pharmacol. Exp. Ther. 173, 145–151 (1970)
Akera, T., Hook, J.B., Tobin, T., Brody, T.M.: Cardiac glycoside sensitivity of (Na + K+)-activated ATPase in new-born rats. Res. Commun. Chem. Pathol. Pharmacol. 4, 699–706 (1972)
Akera, T., Baskin, S.I., Tobin, T., Brody, T.M.: Ouabain: Temporal relationship between the inotropic effect and the in vitrobinding to, and dissociation from, (Na ++K+)-activated ATPase. Naunyn-Schmiedebergs Arch. Pharmacol. 277, 151–162 (1973)
Akera, T., Brody, T.M., So, R.H.-M., Tobin, T., Baskin, S.I.: Factors and agents that in-fluence cardiac glycoside-Na+, K +-ATPase interaction. Ann. N.Y. Acad. Sci. 242, 617–634 (1974a)
Akera, T., Tobin, T., Gatti, A., Shieh, I.-S., Brody, T.M.: Effect of potassium on the conformational state of the complex of ouabain with sodium-and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 10, 509–518 (1974b)
Akera, T., Bennet, R.T., Olgaard, M.K., Brody, T.M.: Cardiac Na+, K+-adenosine triphosphatase inhibition by ouabain and myocardial sodium: A computer simulation. J. Pharmacol. Exp. Ther. 199, 287–297 (1976a)
Akera, T., Ku, D., Tobin, T., Brody, T.M.: The complexes of ouabain with sodium and potassium activated adenosine triphosphatase formed with various ligands: Relationship to the complex formed in the beating heart. Mol. Pharmacol. 12, 101–114 (1976b)
Akera, T., Ku, D., Brody, T.M.: Lack of effect on brain stem and cerebral cortex Na+, K+-ATPase during heart block produced by chronic digoxin treatment. Eur. J. Pharmacol. 45, 243–249 (1977a)
Akera, T., Olgaard, M.K., Temma, K., Brody, T.M.: Development of the positive inotropic action of ouabain: Effects of transmembrane sodium movement. J. Pharmacol. Exp. Ther. 203, 675–684 (1977b)
Akera, T., Temma, K., Wiest, S.A., Brody, T.M.: Reduction of the equilibrium binding of cardiac glycosides and related compounds to Na+, K+-ATPase as a possible mechanism for the potassium-induced reversal of their toxicity. Naunyn-Schmiedebergs Arch. Pharmacol. 304, 157–165 (1978)
Akera, T., Brody, T.M., Wiest, S.A.: Saturable adenosine 5’-triphosphate-independent binding of (3H)-ouabain to brain and cardiac tissue in vitro. Brit. J. Pharmacol. 65, 403–409 (1979a)
Akera, T., Choi, Y.R., Yamamoto, S.: Potassium-induced changes in Na, K-ATPase: Influences on the interaction between cardiac glycosides and enzyme. In: Na, K-ATPase: Structure and Kinetics. Skou, J.C., Nerby, J.G. (eds.), pp. 405–420. London: Academic Press 1979b
Akera, T., Wiest, S.A., Brody, T.M.: Differential effect of potassium on the action of di- goxin and digoxigenin in guinea-pig heart. Eur. J. Pharmacol. 57, 343–351 (1979c)
Akera, T., Yamamoto, S., Chubb, J., McNish, R., Brody, T.M.: Biochemical basis for the low sensitivity of the rat heart to digitalis. Naunyn-Schmiedebergs Arch. Pharmacol. 308, 81–88 (1979d)
Albers, R.W., Koval, G.J., Siegel, G.J.: Studies on the interaction of ouabain and other cardioactive steroids with sodium-potassium-activated adenosine triphosphatase. Mol. Pharmacol. 4, 324–336 (1968)
Allen, D.G., Blinks, J R • Calcium transients in aequorin-injected frog cardiac muscle. Nature (Lond.) 273, 509–513 (1978)
Allen, J.C., Schwartz, A.: A possible biochemical explanation for the insensitivity of the rat to cardiac glycosides. J. Pharmacol. Exp. Ther. 168, 42–46 (1969)
Allen, J.C., Schwartz, A.: Effects of potassium, temperature, and time on ouabain interaction with the cardiac Na+, K+-ATPase: Further evidence supporting an allosteric site. J. Mol. Cell. Cardiol. 1, 39–45 (1970)
Allen, J.C., Schwartz, A.: Human cardiac Na+, K+-ATPase: A pharmacologic receptor for cardiac glycosides. Cardiovasc. Res. Center Bull. 10, 133–141 (1972)
Allen, J.C., Besch, H.R. Jr., Glick, G., Schwartz, A.: The binding of tritiated ouabain to sodium-and potassium-activated adenosine triphosphatase and cardiac relaxing system of perfused dog heart. Mol. Pharmacol. 6, 441–443 (1970a)
Allen, J.C., Lindenmayer, G.E., Schwartz, A.: An allosteric explanation for ouabain-induced time-dependent inhibition of sodium, potassium-adenosine triphosphatase. Arch. Biochem. Biophys. 141, 322–328 (1970b)
Allen, J.C., Harris, R.A., Schwartz, A.: The nature of the transport ATPase-digitalis complex. I. Formation and reversibility in the presence and absence of a phosphorylated enzyme. Biochem. Biophys. Res. Commun. 42, 366–370 (1971a)
Allen, J.C., Harris, R.A., Schwartz, A.: The nature of the transport ATPase-digitalis complex. II. Some species differences and ouabain “exchange” characteristics. J. Mol. Cell. Cardiol. 3, 297–300 (1971b)
Allen, J.C., Martines-Maldonado, M., Eknoyan, G., Suki, W.N., Schwartz, A.: Relation between digitalis binding in vivo and inhibition of sodium, potassium-adenosine triphosphatase in canine kidney. Biochem. Pharmacol. 20, 73–80 (1971c)
Allen, J.C., Entman, M.L., Schwartz, A.: The nature of the transport adenosine triphos-phatase-digitalis complex. VIII. The relationship between in vivo-formed (3H-ouabainNa+, K +-adenosine triphosphatase) complex and ouabain-induced positive inotropism. J. Pharmacol. Exp. Ther. 192, 105–112 (1975)
Asano, Y., Liberman, U.A., Edelman, I.S.: Thyroid thermogenesis: Relationships between Na+-dependent respiration and Na +K+-adenosine triphosphatase activity in rat skeletal muscle. J. Clin. Invest. 57, 368–379 (1976)
Ash, A.S.F., Schwartz, A.: Sodium-plus-potassium ion-activated adenosine triphosphatase in a heavy-membrane fraction isolated from rat skeletal muscle. Biochem. J. 118, 20P–21P (1970)
Baker, P.F., Willis, J.S.: On the number of sodium pumping sites in cell membranes. Biochim. Biophys. Acta (Amst.) 183, 646–649 (1969)
Baker, P.F., Willis, J.S.: Potassium ions and the binding of cardiac glycosides to mammalian cells. Nature (Lond.) 226, 521–523 (1970)
Baker, P.F., Willis, J S • Inhibition of the sodium pump in squid giant axons by cardiac glycosides: The dependence on extracellular ions and metabolism. J. Physiol. (Lond.) 224, 463–475 (1972)
Balasubramanian, V., McNamara, D.B., Singh, J.N., Dhalla, N.S.: Biochemical basis of heart function. X. Reduction in the Na+-K+-stimulated ATPase activity in failing rat heart due to hypoxia. Can. J. Physiol. Pharmacol. 51, 504–510 (1973)
Barnett, R.E.: Effect of monovalent cations on the ouabain inhibition of the sodium and potassium ion activated adenosine triphosphatase. Biochemistry 9, 4644–4648 (1970)
Baskin, S.I., Akera, T., Puckett, C.R., Brody, S.L., Brody, T.M.: Effect of potassium canrenoate on cardiac functions and (Na+ + K +)-activated ATPase. Proc. Soc. Exp. Biol. Med. 143, 495–498 (1973)
Beauge, L.A., Adragna, N.: The kinetics of ouabain inhibition and the partition of rubidium influx in human red blood cells. J. Gen. Physiol. 57, 576–592 (1971)
Beard, N.A., Rouse, W., Somerville, A.R.: Cardiotonic steroids: Correlation of sodium-potassium adenosine triphosphate inhibition and ion transport in vitro with inotropic activity and toxicity in dogs. Br. J. Pharmacol. 54, 65–74 (1975)
Beller, G.A., Conroy, J., Smith, T.W.: Ischemia-induced alterations in myocardial (Na++K+)-ATPase and cardiac glycoside binding. J. Clin. Invest. 57, 341–350 (1976)
Bentfeld, M., Lüllmann, H., Peters, T., Proppe, D.: Interdependence of ion transport and the action of ouabain in heart muscle. Brit. J. Pharmacol. 61, 19–27 (1977)
Bergelson, L.D., Barsukov, L.I.: Topological asymmetry of phospholipids in membranes. Science 197, 224–230 (1977)
Besch, H.R. Jr., Schwartz, A.: On the mechanism of action of digitalis. J. Mol. Cell. Cardiol. 1, 195–199 (1970)
Besch, H.R. Jr., Allen, J.C., Glick, G., Schwartz, A.: Correlation between the inotropic action of ouabain and its effects on subcellular enzyme systems from canine myocardium. J. Pharmacol. Exp. Ther. 171, 1–12 (1970)
Besch, H.R. Jr., Jones, L.R., Watanabe, A.M.: Intact vesicles of canine cardiac sarcolemma: Evidence from vectorial properties of Na+, K+-ATPase. Circ. Res. 39, 586–595 (1976)
Blaustein, M.P.: Sodium-calcium exchange and the regulation of cell calcium in muscle fi-bers. Physiologist 19, 525–540 (1976)
Blood, B.E., Noble, D.: Glycoside induced inotropism of the heart — more than one mechanism? J. Physiol. (Lond.) 266, 76P–78P (1977)
Bluschke, V., Bonn, R., Greeff, K.: Increase in the (Na+ + K +)-ATPase activity in heart muscle after chronic treatment with digitoxin or potassium defficient diet. Europ. J. Pharmacol. 37, 189–191 (1976)
Bodemann, H.H., Hoffman, J.F.: Side-dependent effects of internal versus external Na and K on ouabain binding to reconstituted human red blood cell ghosts. J. Gen. Physiol. 67, 497–525 (1976a)
Bodemann, H.H., Hoffman, J.F.: Comparison of the side-dependent effects of Na and K on orthophosphate-, UTP-, and ATP-promoted ouabain binding to reconstituted human red blood cell ghosts. J. Gen. Physiol. 67, 527–545 (1976b)
Bonn, R., Greeff, K.: The effect of chronic administration of digitoxin on the activity of the myocardial (Na + K)-ATPase in guinea-pigs. Arch. Int. Pharmacodyn. 233, 53–64 (1978)
Borsch-Galetke, E., Dransfeld, H., Greeff, K.: Specific activity and sensitivity of strophanthin of the Na++K+-activated ATPase in rats and guinea-pigs with hypoadrenalism. Naunyn-Schmiedebergs Arch. Pharmacol. 274, 74–80 (1972)
Böttcher, H., Fischer, K., Proppe, D.: Untersuchungen über die Wirkung von Digoxigeninmono-, -bis-and -tridigitoxosid am Herz-Lungen-Präparat der Katze. Basic. Res. Cardiol. 70, 279–291 (1975)
Boutagy, J., Gelbart, A., Thomas, R.: Cardenolide analogues. IV. Inhibition of Na+, K+-ATPase. Aust. J. Pharmaceut. Sci. NS2, 41–46 (1973)
Brennan, F.J., McCans, J.L., Chiong, M.A., Parker, J.O.: Effects of ouabain on myocardial potassium and sodium balance in man. Circulation 45, 107–113 (1972)
Brody, T.M., Akera, T.: Relations among Na+, K+-ATPase activity, sodium pump activity, transmembrane sodium movement, and cardiac contractility. Fed. Proc. 36, 2219–2224 (1977)
Brown, T.E., Acheson, G.H., Grupp, G.: The saturated-lactone glycoside dihydro-ouabain: Effects on potassium balance of the dog heart. J. Pharmacol. Exp. Ther. 136, 107–113 (1962)
Byrne, J.E., Dresel, P.E.: The effect of temperature and calcium concentration on the action of ouabain in quiescent rabbit atria. J. Pharmacol. Exp. Ther. 166, 354–363 (1969)
Caldwell, R.W., Nash, C.B.: Comparison of effects of aminosugar cardiac glycosides with ouabain and digoxin on Na+, K +-adenosine triphosphatase and cardiac contractile force. J. Pharmacol. Exp. Ther. 204, 141–148 (1977)
Chang, C.C., Trosko, J.E., Akera, T.: Characterization of ultraviolet light-induced ouabainresistant mutations in Chinese hamster cells. Mutation Res. 51, 85–98 (1978)
Charnock, J.S., Potter, H.A.: The effect of Mg’ and ouabain on the incorporation of P32 from ATV’ into Na+- and K+-activated adenosine triphosphatase. Arch. Biochem. Biophys. 134, 42–47 (1969)
Charnock, J.S., Rosenthal, A.S., Post, R.L.: Studies of the mechanism of cation transport. II. A phosphorylated intermediate in the cation stimulated enzymic hydrolysis of adenosine triphosphate. Aust. J. Exp. Biol. 41, 675–686 (1963)
Charnock, J.S., Almeida, A.F., To, R.: Temperature-activity relationships of cation activation and ouabain inhibition of (Na+ +K+)-ATPase. Arch. Biochem. Biophys. 167, 480487 (1975)
Charnock, J.S., Simonson, L.P., Almeida, A.F.: Variation in sensitivity of the cardiac glycoside receptor characteristics of (Na + + K+)-ATPase to lipolysis and temperature. Biochim. Biophys. Acta (Amst.) 465, 77–92 (1977)
Choi, Y.R., Akera, T.: Kinetic studies on the interaction between ouabain and (Na +, K+)-ATPase. Biochim. Biophys. Acta (Amst.) 481, 648–659 (1977)
Choi, Y.R., Akera, T.: Membrane (Na + + K +)-ATPase of canine brain, heart, and kidney: Tissue dependent differences in kinetic properties and the influence of purification procedures. Biochim Biophys. Acta (Amst.) 508, 313–327 (1978)
Clark, A.F., Swanson, P.D., Stahl, W.L.: Increase in dissociation rate constants of cardiotonic steroid-brain (Na + + K+)-ATPase complexes by reduction of unsaturated lactone. J. Biol. Chem. 250, 9355–9359 (1975)
Clausen, T., Hansen, O.: Ouabain binding and Na + -K + transport in rat muscle cells and adipocytes. Biochim. Biophys. Acta (Amst.) 345, 387–404 (1974)
Cohen, I., Daut, J., Noble, D.: An analysis of the actions of low concentrations of ouabain on membrane currents in Purkinje fibres. J. Physiol. (Lond.) 260, 75–103 (1976)
Curfman, G.D., Crowley, T.J., Smith, T.W.: Thyroid-induced alterations in myocardial sodium-and potassium-activated adenosine triphosphatase, monovalent cation active transport, and cardiac glycoside binding. J. Clin. Invest. 59, 586–590 (1977)
DePont, J.J.H.H.M., Bonting, S.L.: The role of phospholipids in Na-K-ATPase. In: Bazan, N.G., Brenner, R.R., Guisto, N.M. (eds.). Function and biosynthesis of lipids, pp. 219224. New York: Plenum Publ. Corp. 1977
DePover, A., Godfraind, T.: Sensitivity to cardiac glycosides of (Na + K) ATPase prepared from human heart, guinea-pig heart, and guinea-pig brain. Arch. Int. Pharmacodyn. Ther. 221, 339–341 (1976)
Dhalla, N.S., Singh, J.N., Fedelesova, M., Balasubramanian, V., McNamara, D.B.: Biochemical basis of heart function. XII. Sodium-potassium stimulated adenosine triphosphatase activity in the perfused heart made to fail by substrate-lack. Cardiovasc. Res. 8, 227–236 (1974)
Dransfeld, H., Greeff, K., Berger, H., Cautius, V.: Die verschiedene Empfindlichkeit der Na++K+-aktivierten ATPase des Herz-and Skeletmuskels gegen k-Strophanthin. Naunyn-Schmiedebergs Arch. Pharmacol. 254, 225–234 (1966)
Dransfeld, H., Greeff, K., Schorn, A., Ting, B.T.: Calcium uptake in mitochondria and vesicles of heart and skeletal muscle in presence of potassium, sodium, k-strophanthin, and pentobarbital. Biochem. Pharmacol. 18, 1335–1345 (1969)
Dudding, W.F., Winter, C.G.: On the reaction sequence of the K+-dependent acetyl phos-phatase activity of the Na+ pump. Biochim. Biophys. Acta (Amst.) 241, 650–660 (1971)
Dunham, E.T., Glynn, I.M.: Adenosine triphosphatase activity and the active movements of alkali metal ions. J. Physiol. (Lond.) 156, 274–293 (1961)
Dutta, S., Goswami, S., Datta, D.K., Lindower, J.O., Marks, B.H.: The uptake and binding of six radiolabeled cardiac glycosides by guinea-pig hearts and by isolated sarcoplasmic reticulum. J. Pharmacol. Exp. Ther. 164, 10–21 (1968)
Ebner, F., Reiter, M.: The dependence on contraction frequency of the positive inotropic effect of dihydro-ouabain. Naunyn-Schmiedebergs Arch. Pharmacol. 300, 1–9 (1977)
Edelman, I.S.: Thyroidal regulation of renal energy metabolism and (Na+ + K +)-activated adenosine triphosphatase activity. Med. Clin. N. Amer. 59, 605–614 (1975)
Entman, M.L., Allen, J.C., Schwartz, A.: Calcium-ouabain interaction in a “microsomal” membrane fraction containing Na, K+-ATPase activity and calcium binding activity. J. Mol. Cell. Cardiol. 4, 435–441 (1972)
Erdmann, E., Hasse, W.: Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes. J. Physiol. (Lond.) 251, 671–682 (1975)
Erdmann, E., Schoner, W.: Ouabain-receptor interactions in (Na+K+)-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants. Biochim. Biophys. Acta (Amst.) 307, 386–398 (1973a)
Erdmann, E., Schoner, W.: Ouabain-receptor interactions in (Na+ + K +)-ATPase preparations. II. Effects of cations and nucleotides on rate constants and dissociation constants. Biochim. Biophys. Acta (Amst.) 330, 302–315 (1973b)
Erdmann, E., Schoner, W.: Ouabain-receptor interactions in (Na+ +K+)-ATPase preparations. III. On the stability of the ouabain receptor against physical treatment, hydrolases, and SH reagents. Biochim. Biophys. Acta (Amst.) 330, 316–324 (1973c)
Erdmann, E., Schoner, W.: Ouabain-receptor intüractions in (Na ++K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor. Naunyn-Schmiedebergs Arch. Pharmacol. 283, 335–356 (1974a)
Erdmann, E., Schoner, W.: Eigenschaften des Rezeptors für Herzglykoside. Klin. Wochenschr. 52, 705–718 (1974b)
Erdmann, E., Bolte, H.-D., Luderitz, B.: The (Na+ + K +)-ATPase activity of guinea pig heart muscle in potassium deficiency. Arch. Biochem. Biophys. 145, 121–125 (1971)
Erdmann, E., Bolte, H.-D., Schoner, W.: Cardiac glycoside receptor in potassium depletion. Recent Adv. in studies on cardiac structure and metabolism. Basic functions of cations in myocardial activity. Fleckenstein, A., Dhalla, N.S. (eds.), Vol. 5, pp. 351–358. Baltimore: University Park Press 1975
Erdmann, E., Patzelt, R., Schoner, W.: The cardiac glycoside receptor: Its properties and its correlation to nucleotide binding sites, phosphointermediate, and (Na + + K +)- ATPase activity. Recent Adv. in studies on cardiac structure and metabolism. The Sarcolemma. Roy, P-E., Dhalla, N.S. (eds.), Vol. 9, pp. 329–335. Baltimore: University Park Press 1976a
Erdmann, E., Philipp, G., Tanner, G.: Ouabain-receptor interactions in (Na + + K +)-ATPase preparations. A contribution to the problem of nonlinear Scatchard plots. Biochim. Biophys. Acta (Amst.) 455, 287–296 (1976b)
Erlij, D., Elizalde, A.: Rapidly reversible inhibition of frog muscle sodium pump caused by cardiotonic steroids with modified lactone rings. Biochim. Biophys. Acta (Amst.) 345, 49–54 (1974)
Flasch, H., Heinz, N.: Correlation between inhibition of (Na+ + K +)-membrane-ATPase and positive inotropic activity of cardenolides in isolated papillary muscles of guinea pig. Naunyn-Schmiedebergs Arch. Pharmacol. 304, 37–44 (1978)
Forbush, B., Kaplan, J.H., Hoffman, J.F.: Characterization of a new photoaffinity derivative of ouabain: Labeling of the large polypeptide and of a proteolipid component of the Na, K-ATPase. Biochemistry 17, 3667–3676 (1978)
Fricke, U.: Lack of interaction of spironolactone with ouabain in guinea pig isolated heart muscle praparations. Eur. J. Pharmacol. 49, 363–371 (1978)
Fricke, U., Klaus, W.: Die Reversibilität der Wirkung von Digitoxin, Strophanthidin und Strophanthidin-3-bromazetat am Papillarmuskel und einer mikrosomalen Na+-K+-aktivierbaren ATPase des Meerschweinchens. Experientia 25, 685–686 (1969)
Fricke, U., Klaus, W.: Comparative studies of the influence of various K+ concentrations on the action of k-strophanthidin, digitoxin, and strophanthidin-3-bromoacetate on papillary muscle and on membrane-ATPase of guinea pig hearts. Eur. J. Pharmacol. 15, 1–7 (1971a)
Fricke, U., Klaus, W.: Über die Wirkung von Strophanthidin-3-bromacetat am Papillarmuskel des Meerschweinchens. Naunyn-Schmiedebergs Arch. Pharmacol. 268, 192–199 (1971b)
Fricke, U., Klaus, W.: Die Haftung verschiedener Cardenolide am Papillarmuskel und einer mikrosomalen ATPase des Meerschweinchenherzens. Naunyn-Schmiedebergs Arch. Pharmacol. 268, 200–209 (1971c)
Fricke, U., Klaus, W.: Evidence for two different Na+-dependent (3H)-ouabain binding sites of a Na+-K+-ATPase of guinea-pig hearts. Brit. J. Pharmacol. 61, 423–428 (1977)
Fricke, U., Klaus, W.: Sodium-dependent cardiac glycoside binding: Experimental evidence and hypothesis. Brit. J. Pharmacol. 62, 255–257 (1978)
Fricke, U., Hollborn, U., Klaus, W.: Inotropic action, myocardial uptake, and subcellular distribution of ouabain, digoxin, and digitoxin in isolated rat hearts. Naunyn-Schmiedebergs Arch. Pharmacol. 288, 195–214 (1975)
Fujino, S., Kawagishi, S., Eguchi, N., Tanaka, M.: Binding site of ouabain in cardiac muscle cell and its positive inotropic effect in cat. Jpn. J. Pharmacol. 21, 423–425 (1971)
Gardner, J.D., Kiino, D.R.: Ouabain binding and cation transport in human erythrocytes. J. Clin. Invest. 52, 1845–1851 (1973)
Gervais, A., Lane, L.K., Anner, B.M., Lindenmayer, G.E., Schwartz, A.: A possible molecular mechanism of the action of digitalis. Ouabain action on calcium binding to sites associated with a purified sodium-potassium-activated adenosine triphosphatase from kidney. Circ. Res. 40, 8–14 (1977)
Glitsch, H.G.: Hemmung der elektrogenen Na-Pumpe am Meerschweinchenvorhof durch Digitoxigenin. Pflügers Arch. 335, 243–251 (1972)
Glitsch, H.G.: An effect of the electrogenic sodium pump on the membrane potential in beating guinea-pig atria. Pflügers Arch. 344, 169–180 (1973)
Glynn, I.M.: The action of cardiac glycosides on ion movements. Pharmacol. Rev. 16, 381–407 (1964)
Godfraind, T.: The therapeutic mode of action of cardiac glycosides. Arch. Int. Pharmacodyn. Ther. 206, 384–388 (1973)
Godfraind, T., Ghysel-Burton, J.: Binding sites related to ouabain-induced stimulation or inhibition of the sodium pump. Nature (Lond.) 265, 165–166 (1977)
Goodman, S.L., Wheeler, K.P.: Ouabain binding to phospholipid-dependent adenosine triphosphatase. Biochem. J. 169, 313–320 (1977)
Goldman, R.H., Coltart, D.J., Friedman, J.P., Nola, G.T., Berke, D.K., Schweizer, E., Harrison, D.C.: The inotropic effects of digoxin in hyperkalemia. Relation to (Na, K+)ATPase inhibition in the intact animal. Circulation 48, 830–838 (1973)
Goldman, R.H., Coltart, D.J., Schweizer, E., Snidow, G., Harrison, D.C.: Dose response in vivo to digoxin in nonno-and hyperkalaemia: Associated biochemical changes. Cardiovasc. Res. 9, 515–523 (1975)
Grobecker, V.H., Piechowski, U., Greeff, K.: Die Wirkung des k-Strophanthins und Digitonins auf den lonentransport und die Membran-ATPase der Erythrocyten von Menschen, Meerschweinchen und Ratten. Med. Exp. 9, 273–282 (1963)
Gubitz, R.H., Akera, T., Brody, T.M.: Control of brain slice respiration by (Na+ + K +)- activated adenosine triphosphatase and the effects of enzyme inhibitors. Biochim. Biophys. Acta (Amst.) 459, 263–277 (1977)
Hajdu, S., Leonard, E.: The cellular basis of cardiac glycoside action. Pharmacol. Rev. 11, 173–209 (1959)
Hall, R.J., Gelbart, A., Silverman, M., Goldman, R.H.: Studies on digitalis-induced arrhythmias in glucose-and insulin-induced hypokalemia. J. Pharmacol. Exp. Ther. 201, 711–722 (1977)
Hansen, O.: The relationship between g-strophanthin-binding capacity and ATPase activity in plasma-membrane fragments from ox brain. Biochim. Biophys. Acta (Amst.) 233, 122–132 (1971)
Hansen, O.: Non-uniform populations of g-strophanthin binding sites of (Na ++K+)-activated ATPase: Apparent conversion to uniformity by K Biochim. Biophys. Acta (Amst.) 433, 383–392 (1976)
Hansen, O.: The effect of sodium on inorganic phosphate-and paranitrophenyl phosphate-facilitated ouabain binding to (Na ++K+)-activated ATPase. Biochim Biophys. Acta (Amst.) 511, 10–22 (1978)
Hansen, O., Jensen, J., Norby, J.G.: Mutual exclusion of ATP, ADP, and g-strophanthin binding to NaK-ATPase. Nature New Biol. 234, 122–124 (1971)
Harris, W.E., Swanson, P.D., Stahl, W.L.: Ouabain binding sites and the (Na+, K+)ATPase of brain microsomal membranes. Biochim. Biophys. Acta (Amst.) 298, 680–689 (1973)
Haustein, K.-O.: Studies on cardioactive steroids. I. Structure-activity relationships on the isolated atrium. Pharmacology 11, 117–126 (1974)
Haustein, K.-O., Hauptmann, J.: Studies on cardioactive steroids. Pharmacology 11, 129138 (1974)
Hegyvary, C.: Covalent labeling of the digitalis-binding component of plasma membranes. Mol. Pharmacol. 11, 588–594 (1975)
Hegyvary, C.: Ouabain binding and phosphorylation of (Na ++K+)-ATPase treated with N-ethylmaleimide or oligomycin. Biochim. Biophys. Acta (Amst.) 422, 365–379 (1976)
Hegyvary, C.: Alterations of cardiac NaK-ATPase by the thyroid state in the rat. Res. Commun. Chem. Path. Pharmacol. 17, 689–702 (1977)
Hegyvary, C., Post, R.L.: Binding of adenosine triphosphate to sodium and potassium ion-stimulated adenosine triphosphatase. J. Biol. Chem. 246, 5234–5240 (1971)
Heinen, E., Noack, E.: Effects of k-strophanthin and digitoxigenin on contractile force, calcium content and exchange in guinea-pig isolated atria. Naunyn-Schmiedebergs Arch. Pharmacol. 275, 359–371 (1972)
Hess, H.H., Pope, A.: Effect of metal cations on adenosine triphosphatase activity of rat brain. Fed. Proc. 16, 196 (1957)
Hilden, S., Rhee, H.M., Hokin, L.E.: Sodium transport by phospholipid vesicles containing purified sodium and potassium ion-activated adenosine triphosphatase. J. Biol. Chem. 249, 7432–7440 (1974)
Hoffman, J.F.: The red cell membrane and the transport of sodium and potassium. Am. J. Med. 41, 666–680 (1966)
Hoffman, J.F.: The interaction between tritiated ouabain and the Na-K pump in red blood cells. J. Gen. Physiol. 54, 343S–350S (1969)
Hokin, L.E., Dahl, J.L., Deupree, J.D., Dixon, J.F., Hackney, J.F., Perdue, J.F.: Studies on the characterization of the sodium-potassium transport adenosine triphosphatase. X. Purification of the enzyme from the rectal gland of Squalus acanthias. J. Biol. Chem. 248, 2593–2605 (1973)
Hougen, T.J., Smith, T.W Inhibition of myocardial monovalent cation active transport by subtoxic doses of ouabain in the dog. Circ. Res. 42, 856–863 (1978)
Huang, W., Askari, A.: Transport ATPase of erythrocyte membrane: Sensitivities of Na, K+-ATPase and K+-phosphatase activities to ouabain. Arch. Biochem. Biophys. 175, 185–189 (1976)
Inagaki, C., Lindenmayer, G.E., Schwartz, A.: Effects of sodium and potassium on binding of ouabain to the transport adenosine triphosphatase. J. Biol. Chem. 249, 5135–5140 (1974)
Jones, L.R., Besch, H.R. Jr., Watanabe, A.M.: Significance of a cardiac microsomal Na plus K+-stimulated ATPase apparently insensitive to ouabain. Fed. Proc. 35, 833 (1976)
Jorgensen, P.L.: Purification of Nat, K+-ATPase: Active site determination and criteria of purity. Ann. N.Y. Acad. Sci. 242: 36–52 (1974)
Jorgensen, P.L.: Purification and characterization of (Nat, K+)-ATPase. V. Conformational changes in the enzyme transitions between the Na-form and the K-form studied with tryptic digestion as a tool. Biochim. Biophys. Acta (Amst.) 401, 399–415 (1975)
Jorgensen, P.L., Skou, J.C.: Purification and characterization of (Na ++K+)-ATPase. I. The influence of detergents on the activity of (Na+ +K+)-ATPase in preparations from the outer medulla of rabbit kidney. Biochim. Biophys. Acta (Amst.) 233, 366–380 (1971)
Jorgensen, P.L., Hansen, O., Glynn, I.M., Cavieres, J.D.: Antibodies to pig kidney (Na+ +K+)-ATPase inhibit the Na+ pump in human red cells provided they have access to the inner surface of the cell membrane. Biochim. Biophys. Acta (Amst.) 291, 795–800 (1973)
Kim, N.D., Bailey, L.E., Dresel, P.E.: Correlation of the subcellular distribution of digoxin with the positive inotropic effect. J. Pharmacol. Exp. Ther. 181, 377–385 (1972)
Köhler, E., Greeff, K.: Der Einfluß des Blut-pH auf die Toxicität herzwirksamer Glycoside. Res. Exp. Med. 159, 65–74 (1972)
Ku, D., Akera, T., Pew, C.L., Brody, T.M.: Cardiac glycosides: Correlation among Na+, K+-ATPase, sodium pump and contractility in the guinea pig heart. Naunyn-Schmiedebergs Arch. Pharmacol. 285, 185–200 (1974)
Ku, D.D., Akera, T., Tobin, T., Brody, T.M.: Comparative species studies on the effect of monovalent cations and ouabain on cardiac Na, K+-ATPase and contractile force. J. Pharmacol. Exp. Ther. 197, 458–469 (1976)
Ku, D.D., Akera, T., Brody, T.M., Weaver, L.C.: Chronic digoxin treatment on canine myocardial Na+, K+-ATPase. Naunyn-Schmiedebergs Arch. Pharmacol. 301, 39–47 (1977)
Kyte, J.: Phosphorylation of a purified (Na + + K +) adenosine triphosphatase. Biochem. Biophys. Res. Commun. 43, 1259–1265 (1971)
Kyte, J.: The titration of the cardiac glycoside binding site of the (Na+ + K +)-adenosine triphosphatase. J. Biol. Chem. 247, 7634–7641 (1972)
Kyte, J.: The reactions of sodium and potassium ion-activated adenosine triphosphatase with specific antibodies. J. Biol. Chem. 249, 3652–3660 (1974)
Lane, L.K., Copenhaver, J.H. Jr., Lindenmayer, G.E., Schwartz, A.: Purification and characterization of and (3H)-ouabain binding to the transport adenosine triphosphatase from outer medulla of canine kidney. J. Biol. Chem. 248, 7197–7200 (1973)
Lane, L.K., Anner, B.M., Wallick, E.T., Ray, M.V., Schwartz, A.: Effect of phospholipase A treatment on the partial reactions of and ouabain binding to a purified sodium and potassium activated adenosine triphosphatase. Biochem. Pharmacol. 27, 225–231 (1977)
Langer, G.A.: Ion fluxes in cardiac excitation and contraction and their relation to myocardial contractility. Physiol. Rev. 48, 708–757 (1968)
Langer, G.A.: The intrinsic control of myocardial contraction–ionic factors. New Engl. J. Med. 285, 1065–1071 (1971)
Langer, G.A.: Effects of digitalis on myocardial ionic exchange. Circulation 46, 180–187 (1972a)
Langer, G.A.: Myocardial K+ loss and contraction frequency. J. Mol. Cell. Cardiol. 4, 85–86 (1972b)
Langer, G.A.: Relationship between myocardial contractility and the effects of digitalis on ionic exchange. Fed. Proc. 36, 2231–2234 (1977)
Langer, G.A., Serena, S.D.: Effects of strophanthidin upon contraction and ionic exchange in rabbit ventricular myocardium: Relative to control of active state. J. Mol. Cell. Cardiol. 1, 65–90 (1970)
Lee, C.O., Fozzard, H.A.: Activities of potassium and sodium ions in rabbit neart muscle. J. Gen. Physiol. 65, 695–708 (1975)
Lee, K.S., Klaus, W.: The subcellular basis for the mechanism of inotropic action of cardiac glycosides. Pharmacol. Rev. 23, 193–261 (1971)
Lee, K.S., Yu, D.H.: A study of the sodium-and potassium-activated adenosinetriphosphatase activity of heart microsomal fraction. Biochem. Pharmacol. 12, 1253–1264 (1963)
Lee, K.S., Shin, M.R., Kang, D.H., Chen, K.K.: Studies on the mechanism of cardiac glycoside action. Biochem. Pharmacol. 19, 1055–1069 (1970)
Lelievre, L., Charlemagne, D., Paraf, A.: Plasma membrane studies on drug-sensitive and -resistant cell lines. II. Ouabain sensitivity of (Na + + K +)stimulated Mg’ -ATPase. Biochim. Biophys. Acta (Amst.) 455, 277–286 (1976)
Lin, M.H., Akera, T.: Increased (Na+, K+)-ATPase concentrations in various tissues of rats caused by thyroid hormone treatment. J. Biol. Chem. 253, 723–726 (1978)
Lin, M.H., Romsos, D.R., Akera, T., Leveille, G.A.: Na+, K+-ATPase enzyme units in skeletal muscle from lean and obese mice. Biochem. Biophys. Res. Commun. 80, 398–404 (1978)
Lindenmayer, G.E., Schwartz, A.: Conformational changes induced in Na+, K+-ATPase by ouabain through a K+-sensitive reaction: Kinetic and spectroscopic studies. Arch. Biochem. Biophys. 140, 371–378 (1970)
Lindenmayer, G.E., Schwartz, A.: Nature of the transport adenosine triphosphatase digitalis complex. IV. Evidence that sodium-potassium competition modulates the rate of ouabain interaction with (Na + + K +) adenosine triphosphatase during enzyme catalysis. J. Biol. Chem. 248, 1291–1300 (1973)
Lindenmayer, G.E., Laughter, A.H., Schwartz, A.: Incorporation of inorganic phosphate-32 into a Na+ + K+-ATPase preparation: Stimulation by ouabain. Arch. Biochem. Biophys. 127, 187–192 (1968)
Lishko, V.K., Malysheva, M.K., Grevisirskaya, T.I.: The interaction of the (Na +, K+)-ATPase of erythrocyte ghosts with ouabain. Biochim. Biophys. Acta (Amst.) 288, 103–106 (1972)
Lo, C.S., Edelman, I.S.: Effect of triiodothyronine on the synthesis and degradation of renal cortical (Na+ + K +)-adenosine triphosphatase. J. Biol. Chem. 251, 7834–7840 (1976)
Lo, C.S., August, T.R., Liberman, U.A., Edelman, I.S.: Dependence of renal (Na+ +K+)-adenosine triphosphatase activity on thyroid status. J. Biol. Chem. 251, 7826–7833 (1976)
Löhr, E., Makoski, H.B., Gobbeler, T., Strötges, M.W.: Beitrag zu der Membranpermeabilität von Cardiaca (g-Strophanthin, Digoxin, Oxyfedrin) auf Grund von Mikroautoradiographien am Meerschweinchenherzen. Arzneim. Forsch. (Drug Res.) 21, 921–927 (1971)
Lüllmann, H., Peters, T.: Action of cardiac glycosides on the excitation-contraction coupling in heart muscle. Prog. Pharmacol. 2, 5–57 (1979)
Lüllmann, H., Peters, T.: Studies on the site of action of cardiac glycosides. In: Digitalis. Storstein, O. (ed.), p. 125. Oslo: Gyldendal Norsk Forlag 1974
Lüllmann, H., Peters, T.: On the sarcolemmal site of action of cardiac glycosides. Recent Adv. in studies on cardiac structure and metabolism. The sarcolemma. Roy, P.-E., Dhalla, N.S. (eds.), Vol. 9, pp. 311–328. Baltimore: University Park Press 1976
Lüllmann, H., Peters, T., Preuner, J., Rüther, T.: Influence of ouabain and dihydroouabain on the circular dichroism of cardiac plasmalemmal microsomes. Naunyn-Schmiedebergs Arch. Pharmacol. 290, 1–19 (1975)
Malur, J., Repke, K.R.H.: Modelluntersuchungen über die Beteiligung einer WasserstoffBrücken-Bindung an der Komplexbildung zwischen Cardenolidverbindungen and Na + K+-aktivierter, Mg’ -abhängiger Adenosintriphosphat-Phosphohydrolase. Acta Biol. Med. Ger. 24, K67—K72 (1970)
Matsui, H., Schwartz, A.: Kinetic analysis of ouabain-K + and Na + interaction on a Na+, K+-dependent adenosinetriphosphatase from cardiac tissue. Biochem. Biophys. Res. Commun. 25, 147–152 (1966)
Matsui, H., Schwartz, A.: Mechanism of cardiac glycoside inhibition of the (Na +-K +)-dependent ATPase from cardiac tissue. Biochim. Biophys. Acta (Amst.) 151, 655–663 (1968)
Matsui, H., Hayashi, Y., Homareda, H., Kimimura, M.: Ouabain-sensitive 42K binding to Na +, K+-ATPase purified from canine kidney outer medulla. Biochem. Biophys. Res. Commun. 75, 373–380 (1977)
Mayer, M., Avi-Dor, Y.: Fluorescence of 8-anilino-l-naphthalene-sulfonate bound to ox-brain Nat and K +-stimulated adenosine triphosphatase. Isr. J. Med. Sci. 6, 726–731 (1970)
McCans, J.L., Lane, L.K., Lindenmayer, G.E., Butler, V.P. Jr., Schwartz, A.: Effects of an antibody to a highly purified Na+, K+-ATPase from canine renal medulla: Separation of the “holoenzyme antibody” into catalytic and cardiac glycoside receptor-specific components. Proc. Natl. Acad. Sci. U.S.A. 71, 2449–2452 (1974)
Michael, L., Wallick, E.T., Schwartz, A.: Modification of (Na +, K+)-ATPase function by purified antibodies to the holoenzyme — effects on enzyme activity and 3H ouabain binding. J. Biol. Chem. 252, 8476–8480 (1977)
Michael, L., Pitts, B.J.R., Schwartz, A.: Is pump stimulation associated with positive inotropy of the heart? Science 200, 1287–1289 (1978)
Murthy, R.V., Kidwai, A.M., Daniel, E.E.: Dissociation of contractile effect and binding and inhibition of Na +-K +-adenosine triphosphatase by cardiac glycosides in rabbit myometrium. J. Pharmacol. Exp. Ther. 188, 575–581 (1974)
Nagai, K., Lindenmayer, G.E., Schwartz, A.: Direct evidence for the conformational nature of the Na, K -ATPase system: Fluorescence and circular dichroism studies. Arch. Biochem. Biophys. 139, 252–254 (1970)
Nagatomo, T., Jarmakani, J.M., Philipson, K.D., Nakazawa, M.: Effect of anoxia on membrane-bound ATPase and K+-p-nitrophenyl phosphatase activities in rabbit heart. J. Mol. Cell. Cardiol. 10, 981–989 (1978)
Nâidoo, B.K., Witty, T.R., Remers, W.A., Besch, H.R. Jr.: Cardiotonic steroids: I Impor- tance of 14ß-hydroxy group in digitoxigenin. J. Pharm. Sci. 63, 1391–1394 (1974)
Nayler, W.G., Stone, J., Carson, V., Chipperfield, D.: Effect of ischemia on cardiac contractility and calcium exchangeability. J. Mol. Cell. Cardiol. 2, 125–143 (1971)
Okarma, T.B., Tramell, P., Kalman, S.M.: Inhibition of sodium-and potassium-dependent adenosine triphosphatase by digoxin covalently bound to sepharose. Mol. Pharmacol. 8, 476–480 (1972)
Okita, G.T.: Dissociation of Na, K+-ATPase inhibition from digitalis inotropy. Fed. Proc. 36, 2225–2230 (1977)
Okita, G.T., Richardson, F., Roth-Schechter, B.F.: Dissociation of the positive inotropic action of digitalis from inhibition of sodium-and potassium-activated adenosine triphosphatase. J. Pharmacol. Exp. Ther. 185, 1–11 (1973)
Park, M.K., Vincenzi, F.F.: Rate of onset of cardiotonic steroid-induced inotropism: Influence of temperature and beat interval. J. Pharmacol. Exp. Ther. 195, 140–150 (1975)
Perrone, J.R., Blostein, R.: Asymmetric interaction of inside-out and right-side-out erythrocyte membrane vesicles with ouabain. Biochim. Biophys. Acta (Amst.) 291, 680–689 (1973)
Pert, C., Snyder, S.: Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 10, 868–879 (1974)
Peters, T., Raben, R.H., Wassermann, O.: Evidence for a dissociation between positive isotropic effect and inhibition of the Na +-K + -ATPase by ouabain, cassaine, and their alkylating derivatives. Eur. J. Pharmacol. 26, 166–174 (1974)
Pitts, B.J.R., Wallick, E.T., Van Winkle, W.B., Allen, J.C., Schwartz, A.: On the lack of isotropy of cardiac glycosides on skeletal muscle: A comparison of Na+, K +-ATPases from skeletal and cardiac muscle. Arch. Biochem. Biophys. 184, 431–440 (1977)
Poole-Wilson, P.A., Langer, G.A.: Glycoside inotropy in the absence of an increase in potassium efflux in the rabbit heart. Circ. Res. 37, 390–395 (1975)
Post, R.L., Merritt, C.R., Kinsolving, C.R., Albright, C.D.: Membrane adenosine triphosphatase as a participant in the active transport of sodium and potassium in the human erythrocyte. J. Biol. Chem. 235, 1796–1802 (1960)
Post, R.L., Kume, S., Tobin, T., Orcutt, B., Sen, A.K.: Flexibility of an active center in sodium-plus-potassium adenosine triphosphatase. J. Gen. Physiol. 54, 306S–326S (1969)
Prindle, K.H. Jr., Skelton, C.L., Epstein, S.E., Marcus, F.I.: Influence of extracellular potassium concentration on myocardial uptake and inotropic effect of tritiated digoxin. Circ. Res. 28, 337–345 (1971)
Repke, K.: Metabolism of cardiac glycosides. In: Proc. 1 st International Pharmacol. Meeting, vol. 3, pp. 47–73. Oxford: Pergamon Press 1963
Repke, K.: Über den biochemischen Wirkungsmodus von Digitalis. Klin. Wochenschr. 42, 157–165 (1964)
Repke, K.: Effect of digitalis on membrane adenosine triphosphatase of cardiac muscle. In: Drugs and enzymes. Proc. 2 nd International Pharmacol. Meeting, Prague. Brodie, B.B., Gillette, J. (eds.), vol. 4, pp. 65–87. Oxford: Pergamon, Prague: Chechoslovak Medical Press 1965
Repke, K., Portius, H.J.: Über die Identität der Ionenpumpen-ATPase in der Zellmembran des Herzmuskels mit einem Digitalis-Rezeptorenzym. Experientia 19, 452–458 (1963)
Repke, K.R.H., Schön, R.: Flip-flop model of (NaK)-ATPase function. Acta Biol. Med. Germ. 31, K19—K39 (1973)
Repke, K., Est, M., Portius, H.J.: Über die Ursache der Speciesunterschiede in der Digitalisempfindlichkeit. Biochem. Pharmacol. 14, 1785–1802 (1965)
Reuter, H.: Exchange of calcium ions in the mammalian myocardium: Mechanisms and physiological significance. Circ. Res. 34, 599–605 (1974)
Rhee, H.M., Dutta, S., Marks, B.H.: Cardiac NaK ATPase activity during positive inotro-pic and toxic action of ouabain. Eur. J. Pharmacol. 37, 141–153 (1976)
Ross, C.R., Pessah, N.I.: Reversible inhibition of (Nat +K+)-ATPase with a cardiac gly-coside. Eur. J. Pharmacol. 33, 223–226 (1975)
Roth-Schechter, B.F., Okita, G.T., Thomas, R.E., Richardson, F.F.: On the positive inotropic action of alkylating bromoacetates of strophanthidin and strophanthidol-(19-H3). J. Pharmacol. Exp. Ther. 171, 13–19 (1970)
Ruoho, A., Kyte, J.: Photoaffinity labeling of the ouabain-binding site on (Nat +K+)adenosinetriphosphatase. Proc. Natl. Acad. Sci. U.S.A. 71, 2352–2356 (1974)
Ruoho, A.E., Hokin, L.E., Hemingway, R.J., Kupchan, S.M.: Hellebrigenin 3-haloacetates: Potent site-directed alkylators of transport adenosinetriphosphatase. Science 159, 1354–1355 (1968)
Sachs, J.R.: Interaction of external K, Na, and cardioactive steroids with the Na-K pump of the human red blood cell. J. Gen. Physiol. 63, 123–143 (1974)
Schatzmann, H.J.: Herzglycoside als Hemmstoffe für den aktiven Kalium-und Natrium- transport durch die Erythrocytenmembran. Helv. Physiol. Acta 11, 346–354 (1953)
Scholz, H.: Effect of a “therapeutic” concentration of digitoxigenine on myocardial potassium and sodium content in Ca-poor media. Naunyn-Schmiedebergs Arch. Pharmacol. 273, 434–437 (1972)
Schön, R., Schönfeld, W., Repke, K.R.H.: Zur Charakterisierung des Ouabain-bindenden Konformationszustandes der (Nat +K+)-aktivierten ATPase. Acta Biol. Med. Germ. 24, K61 - K65 (1970)
Schön, R., Schönfeld, W., Menke, K.-H., Repke, K.R.H.: Mechanism and role of Na+/ Ca’ competition in (NaK)-ATPase. Acta Biol. Med. Germ. 29, 643–659 (1972)
Schönfeld, W., Schön, R., Menke, K.-H., Repke, K.R.H.: Identification of conformational states of transport ATPase by kinetic analysis of ouabain binding. Acta Biol. Med. Germ. 28, 935–956 (1972)
Schuurmans Stekhoven, F.M.A.H., DePont, J.J.H.H.M., Bonting, S.L.: Studies on (Na++K+)-activated ATPase. XXXVII. Stabilization by cations of the enzyme-ouabain complex formed with Mg’ and inorganic phosphate. Biochim Biophys. Acta (Amst.) 419, 137–149 (1976)
Schwartz, A.: Is the cell membrane Na+, K +-ATPase enzyme system the pharmacological receptor for digitalis? Circ. Res. 39, 2–7 (1976)
Schwartz, A., Matsui, H., Laughter, A.H.: Tritiated digoxin binding to (Na + + K +)-acti- vated adenosine triphosphatase: Possible allosteric site. Science 160, 323–325 (1968)
Schwartz, A., Allen, J.C., Harigaya, S.: Possible involvement of cardiac Na +, K + -adenosine triphosphatase in the mechanism of action of cardiac glycosides. J. Pharmacol. Exp. Ther. 168, 31–41 (1969)
Schwartz, A., Wood, J.M., Allen, J.C., Bornet, E.P., Entman, M.L., Goldstein, M.A., Sordahl, L.A., Suzuki, M.: Biochemical and morphologic correlates of cardiac ischemia. I. Membrane system. Am. J. Cardiol. 32, 46–61 (1973)
Schwartz, A., Allen, J.C., Van Winkle, W.B., Munson, R.: Further studies on the correlation between the inotropic action of ouabain and its interaction with the Na+, K+-adenosine triphosphatase: Isolated perfused rabbit and cat hearts. J. Pharmacol. Exp. Ther. 191, 119–127 (1974)
Schwartz, A., Lindenmayer, G.E., Allen, J.C.: The sodium-potassium adenosine triphosphatase: Pharmacological, physiological, and biochemical aspects. Pharmacol. Rev. 27, 3–134 (1975)
Sen, A.K., Tobin, T., Post, R.L.: A cycle for ouabain inhibition of sodium-and potassium-dependent adenosine triphosphatase. J. Biol. Chem. 244, 6596–6604 (1969)
Sharma, V.K., Banerjee, S.P.: Specific [3H]ouabain binding to rat heart and skeletal muscle: Effects of thyroidectomy. Mol. Pharmacol. 14, 122–129 (1978)
Siegel, G.J., Josephson, J.: Ouabain reaction with microsomal (sodium-plus-potassium)-activated adenosine-triphosphatase: Characteristics of substrate and ion dependencies. Eur. J. Biochem. 25, 323–335 (1972)
Siegel, G.J., Koval, G.J., Albers, R.W.: Sodium-potassium-activated adenosine triphosphatase. VI. Characterization of the phosphoprotein formed from orthophosphate in the presence of ouabain. J. Biol. Chem. 244, 3264–3269 (1969)
Singh, C.M., Flear, C.T.G., Nandra, A., Ross, D.N.: Electrolyte changes in the human myocardium after anoxic arrest. Cardiology 56, 128–135 (1971)
Skou, J.C.: The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim. Biophys. Acta (Amst.) 23, 394–401 (1957)
Skou, J.C.: Further investigations on a Mg++Na+-activated adenosinetriphosphatase, possibly related to the active, linked transport of Na+ and K+ across the nerve membrane. Biochim. Biophys. Acta (Amst.) 42, 6–23 (1960)
Skou, J.C.: Enzymatic basis for active transport of Na and K across cell membrane. Physiol. Rev. 45, 596–617 (1965)
Skou, J.C.: Study on the influence of the concentration of Mg’, Pi, K+, Na+, and Tris on (Mg2++Pi)-supported G-strophanthin binding to (Na + + K +)-activated ATPase from ox brain. Biochim Biophys. Acta (Amst.) 311, 51–66 (1973)
Skou, J.C., Hilberg, C.: The effect of cations, G-strophanthin and oligomycin on the labeling from (32P) ATP of the (Na+ + K+)-activated enzyme system and the effect of cations and G-strophanthin on the labeling from (32P) ITP and 32Pi. Biochim. Biophys. Acta (Amst.) 185, 198–219 (1969)
Skou, J.C., Butler, K.W., Hansen, O.: The effect of magnesium, ATP, Pi, and sodium on the inhibition of the (Na + + K +)-activated enzyme system by g-strophanthin. Biochim. Biophys. Acta (Amst.) 241, 443–461 (1971)
Smith, T.W., Haber, E.: Digitalis. New Engl. J. Med. 289, 1125–1129 (1973)
Smith, T.W., Wagner, H. Jr.: Effects of (Na + + K +)-ATPase-specific antibodies on enzy-matic activity and monovalent cation transport. J. Membrane Biol. 25, 341–360 (1975)
Smith, T.W., Wagner, H. Jr., Markis, J.E., Young, M.: Studies on the localization of the cardiac glycoside receptor. J. Clin. Invest. 51, 1777–1789 (1972)
Smith, T.W., Wagner, H. Jr., Young, M.: Cardiac glycoside interaction with solubilized myocardial sodium-and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 10, 626–633 (1974)
Stickney, J L Inhibition of 3H-1-norepinephrine uptake by ouabain is species dependent. Res. Commun. Chem. Pathol. Pharmacol. 14, 227–236 (1976)
Swanson, P.D.: Temperature dependence of sodium ion activation of the cerebral microsomal adenosine triphosphatase. J. Neurochem. 13, 229–236 (1966)
Sybers, H.D., Helmer, P.R., Murphy, Q.R.: Effect of hypoxia on myocardial potassium balance. Am. J. Physiol. 220, 2047–2050 (1971)
Taniguchi, K., Iida, S.: The binding of ouabain to Na + -K +-dependent ATPase treated with phospholipase. Biochim. Biophys. Acta (Amst.) 233, 831–833 (1971)
Taniguchi, K., Iida, S.: Two apparently different ouabain binding sites of (Na + + K +)-ATPase. Biochim. Biophys. Acta (Amst.) 288, 98–102 (1972)
Taniguchi, K., Iida, S.: The role of phospholipids in the binding of ouabain to sodium-and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 9, 350–359 (1973)
Thomas, R.C.: Electrogenic sodium pump in nerve and muscle cells. Physiol. Rev. 52, 563–594 (1972)
Thomas, R., Boutagy, J., Gelbart, A.: Cardenolide analogs. V. Cardiotonic activity of semi- synthetic analogs of digitoxigenin. J. Pharmacol. Exp. Ther. 191, 219–231 (1974)
Tobin, T., Brody, T.M.: Rates of dissociation of enzyme-ouabain complexes and K0.5 values in (Na + + K +) adenosine triphosphatase from different species. Biochem. Pharmacol. 21, 1553–1560 (1972)
Tobin, T., Sen, A.K.: Stability and ligand sensitivity of (3H) ouabain binding to (Na ++ K+)-ATPase. Biochim. Biophys. Acta (Amst.) 198, 120–131 (1970)
Tobin, T., Baskin, S.I., Akera, T., Brody, T.M.: Nucleotide specificity of the Na+-stimulated phosphorylation and (3H) ouabain-binding reactions of (Na + + K +)-dependent adenosine triphosphatase. Mol. Pharmacol. 8, 256–263 (1972a)
Tobin, T., Henderson, R., Sen, A.K.: Species and tissue differences in the rate of dissociation of ouabain from (Na + + K +)-ATPase. Biochim. Biophys. Acta (Amst.) 274, 551–555 (1972b)
Tobin, T., Akera, T., Baskin, S.I., Brody, T.M.: Calcium ion and sodium-and potassium-dependent adenosine triphosphatase: Its mechanism of inhibition and identification of the E1-P intermediate. Mol. Pharmacol. 9, 336–349 (1973a)
Tobin, T., Akera, T., Hogg, R.E., Brody, T.M.: Ouabain binding to sodium-and potassium-dependent adenosine triphosphatase- Inhibition by the ß-y-methylene analogue of adenosine triphosphate. Mol. Pharmacol. 9, 278–281 (1973b)
Tobin, T., Akera, T., Ku, D.: Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium-and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 9, 676–685 (1973c)
Tobin, T., Akera, T., Brody, T.M.: Studies on the two phosphoenzyme conformations of Na++K+-ATPase. Ann. N.Y. Acad. Sci. 242, 120–132 (1974a)
Tobin, T., Akera, T., Lee, C.Y., Brody, T.M.: Ouabain binding to (Na+ +K+)-ATPase: Effects of nucleotide analogues and ethacrynic acid. Biochim. Biophys. Acta (Amst.) 345, 102–117 (1974b)
Tuttle, R.S., Witt, P.N., Farah, A.: Therapeutic and toxic effects of ouabain on K+ fluxes in rabbit atria. J. Pharmacol. Exp. Ther. 137, 24–30 (1962)
Vick, R.L., Kahn, J.B.,Jr.: The effects of ouabain and veratridine on potassium movement in the isolated guinea pig heart. J. Pharmacol. Exp. Ther. 121, 389–401 (1957)
Wallick, E.T., Schwartz, A.: Thermodynamics of the rate of binding of ouabain to the sodium, potassium adenosine triphosphatase. J. Biol. Chem. 249, 5141–5147 (1974)
Wallick, E.T., Dowd, F., Allen, J.C., Schwartz, A.: The nature of the transport adenosine triphosphatase-digitalis complex. VII. Characteristics of ouabagenin-Na+, K+-adenosine triphosphatase interaction. J. Pharmacol. Exp. Ther. 189, 434–444 (1974)
Wallick, E.T., Lindenmayer, G.E., Lane, L.K., Allen, J.C., Pitts, B.J.R., Schwartz, A.: Recent advances in cardiac glycoside–Na+, K+-ATPase interaction. Fed. Proc. 36, 2214–2218 (1977)
Weaver, L.C., Akera, T., Brody, T.M.: Digitalis toxicity: Lack of marked effect on brain Na +, K+-adenosine triphosphatase in the cat. J. Pharmacol. Exp. Ther. 200, 638–646 (1977)
Whittam, R., Wheeler, K.P., Blake, A.: Oligomycin and active transport reactions in cell membranes. Nature (Lond.) 203, 720–724 (1964)
Whittam, R., Hallam, C., Wattam, D.G.: Observations on ouabain binding and membrane phosphorylation by the sodium pump. Proc. Roy. Soc. London B 193, 217–234 (1976)
Wilbrandt, W.: Zum Wirkungsmechanismus der Herzglykoside. Schweiz. Med. Wochenschr. 85, 315–320 (1955)
Willerson, J.T., Scales, F., Mukherjee, A., Platt, M., Templeton, G.H., Fink, G.S., Buja, L.M.: Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am. J. Pathol. 87, 159–181 (1977)
Wilson, W.E., Sivitz, W.I., Hanna, L.T.: Inhibition of calf brain membranal sodium-and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model. Mol. Pharmacol. 6, 449–459 (1970)
Yamamoto, S., Akera, T., Brody, T.M.: Sodium influx rate and ouabain-sensitive rubidium uptake in isolated guinea pig atria. Biochim. Biophys. Acta (Amst.) 555, 270–284 (1979)
Yoda, A.: Structure-activity relationships of cardiotonic steroids for the inhibition of sodium-and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate. Mol. Pharmacol. 9, 51–60 (1973)
Yoda, A.: Association and dissociation rate constants of the complexes between various car-diac monoglycosides and Na, K-ATPase. Ann. N.Y. Acad. Sci. 242, 598–616 (1974)
Yoda, A.: Binding of digoxigenin to sodium-and potassium-dependent adenosine triphos-phatase. Mol. Pharmacol. 12, 399–408 (1976)
Yoda, A., Hokin, L.E.: On the reversibility of binding of cardiotonic steroids to a partially purified (Na + K)-activated adenosinetriphosphatase from beef brain. Biochem. Biophys. Res. Commun. 40, 880–886 (1970)
Yoda, A., Hokin, L.E.: Studies on the characterization of the sodium-potassium transport adenosine triphosphatase. VIII. Effects of ligands on fluorescence due to interaction of the enzyme with a fluorescent derivative of Hellebrigenin. Mol. Pharmacol. 8, 30–40 (1972)
Yoda, A., Yoda, S.: Structure-activity relationships of cardiotonic steroids for the inhibition of sodium-and potassium-dependent adenosine triphosphatase. III. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate. Mol. Pharmacol. 10, 494–500 (1974a)
Yoda, A., Yoda, S.: Influence of certain ligands on the dissociation rate constants of cardiac glycoside complexes with sodium-and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 10, 810–819 (1974b)
Yoda, A., Yoda, S.: Structure-activity relationships of cardiotonic steroids for the inhibition of sodium-and potassium-dependent adenosine triphosphatase. V. Dissociation rate constants of digitoxin acetates. Mol. Pharmacol. 11, 653–662 (1975)
Yoda, A., Yoda, S.: Association and dissociation rate constants of the complexes between various cardiac aglycones and sodium-and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate. Mol. Pharmacol. 13, 352–361 (1977)
Yoda, A., Yoda, S.: Influence of pH on the interaction of cardiotonic steroids with sodium-and potassium-dependent adenosine triphosphatase. Mol. Pharmacol. 14, 624–632 (1978)
Yoda, A., Yoda, S., Sarrif, A.M.: Structure-activity relationships of cardiotonic steroids for the inhibition of sodium-and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes. Mol. Pharmacol. 9, 766–773 (1973)
Yoda, S., Sarrif, A.M., Yoda, A.: Structure-activity relationships of cardiotonic steroids for the inhibition of sodium-and potassium-dependent adenosine triphosphatase. IV. Dissociation rate constants for complexes of the enzyme with cardiac oligodigitoxides. Mol. Pharmacol. 11, 647–652 (1975)
Zavecz, J.H., Dutta, S.: The relationship between Na, K+-ATPase inhibition and cardiac glycoside-induced arrhythmia in dogs. Naunyn-Schmiedebergs Arch. Pharmacol. 297, 91–98 (1977)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Akera, T. (1981). Effects of Cardiac Glycosides on Na+, K+-ATPase. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68163-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-68163-9_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68165-3
Online ISBN: 978-3-642-68163-9
eBook Packages: Springer Book Archive